(Q50327490)

4 March 2018

title

Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices, 2013. (English)

1 reference

4 March 2018

Japanese encephalitis virus

main subject

0 references

immunization

0 references

Japanese encephalitis

1 reference

Japanese encephalitis vaccine

inferred from title

1 reference

Centers for Disease Control and Prevention

inferred from title

author

series ordinal

1

object named as

Centers for Disease Control and Prevention (CDC)

1 reference

4 March 2018

1 November 2013

1 reference

4 March 2018

number of pages

3

1 reference

Morbidity and Mortality Weekly Report

inferred from page(s)

published in

1 reference

4 March 2018

volume

62

1 reference

4 March 2018

issue

45

1 reference

4 March 2018

page(s)

898-900

1 reference

4 March 2018

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®).

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC).

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Japanese encephalitis in travelers from non-endemic countries, 1973-2008

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4585349

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

14 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24226626

12 December 2020

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

4585349

1 reference

4 March 2018

PubMed publication ID

24226626

1 reference

4 March 2018